María Ángeles Jiménez‐Sousa

Author

Also Known As

M Angeles Jimenez-Sousa, M Jimenez-Sousa, M Ángeles Jiménez-Sousa, M. A. Jiménez-Sousa, M. A. Jiménez‐Sousa, M. A. Ángeles Jiménez-Sousa, M.a Ángeles Jiménez-Sousa, MA Jiménez‐Sousa, Ma Angeles Jimenez-Sousa, Ma Ángeles Jimenez-Sousa

173

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Instituto de Salud Carlos III Centro Nacional de Microbiologia Hospital General Universitario Gregorio Marañón Hospital Universitario La Paz Hospital Clínico Universitario de Valladolid

MÁ

About

María Ángeles Jiménez‐Sousa is an author at Instituto de Salud Carlos III specializing in medicine, immunology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	437
2	Public Health	2	2	27
3	Health Sciences	1	1	51
4	Biochemistry	1	1	51
5	Cell Biology	1	1	13

María Ángeles Jiménez‐Sousa

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Transcriptomic correlates of organ failure extent in sepsis Raquel Almansa, María Heredia‐Rodríguez, Esther Gómez‐Sánchez, Journal of Infection InflammationPathogenesisCell DeathSepsisInflammatory Marker	2014	121
Epidemiological trends of sepsis in the twenty-first century (2000–2013): an analysis of incidence, mortality, and associated costs in Spain Alejandro Álvaro‐Meca, María Ángeles Jiménez‐Sousa, Dariela Micheloud, Population Health Metrics	2018	88
Plasma miRNA profile at COVID-19 onset predicts severity status and mortality Asier Fernández-Pato, Ana Virseda‐Berdices, Salvador Resino, Emerging Microbes & Infections	2022	88
Metabolic changes during respiratory syncytial virus infection of epithelial cells María Martin‐Vicente, Carolina González-Riaño, Coral Barbas, PLoS ONE Viral ReplicationViral PathogenesisImmunologyMetabolomic ProfilingCellular Physiology	2020	51
Mortality of patients infected with HIV in the intensive care unit (2005 through 2010): significant role of chronic hepatitis C and severe sepsis J. Medraño, Alejandro Álvaro‐Meca, Alexandre Boyer, Critical Care	2014	43
Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients Luz María Medrano, Pilar García‐Broncano, Juan Berenguer, AIDS	2018	43
Evaluation of dried blood spot samples for screening of hepatitis C and human immunodeficiency virus in a real-world setting Sonia Vázquez‐Morón, Pablo Ryan, Beatriz Ardizone-Jiménez, Scientific Reports	2018	40
Increased Th1, Th17 and pro-fibrotic responses in hepatitis C-infected patients are down-regulated after 12 weeks of treatment with pegylated interferon plus ribavirin. María Ángeles Jiménez‐Sousa, Raquel Almansa, Concha de la Fuente, PubMed Liver FibrosisPegylated InterferonMip-1 AlphaHepatitis C VirusImmunology	2010	38
Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients María G. Guzmán, Mónica García–Álvarez, Juan Berenguer, Journal of Infection Hepatitis DPrimary ImmunodeficiencyHepatologyViral HepatitisLiver Physiology	2013	33
Persistence of Clinically Significant Portal Hypertension After Eradication of Hepatitis C Virus in Patients With Advanced Cirrhosis Cristina Díez, Juan Berenguer, Luis Ibáñez, Clinical Infectious Diseases	2020	33

Page 1